Song Chungen
Director/Board Member at ANTELOPE ENTERPRISE HOLDINGS LIMITED
Network origin in Song Chungen first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Sun Yat-Sen University
168
| College/University | Other Consumer Services | 168 |
| Public Company | Building Products | 16 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Song Chungen via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Guangzhou Pharmaceuticals Co., Ltd.
 Guangzhou Pharmaceuticals Co., Ltd. Medical DistributorsDistribution Services Guangzhou Pharmaceuticals Co., Ltd. engages in pharmaceutical distribution and pharmaceutical retail businesses in China. It also involves in the provision of supply chain services, which include pharmaceutical logistics services, as well as consultation services on sales channel management, marketing strategies, and others. The company was founded on January 1, 1951 and is headquartered in Guangzhou, China. | Medical Distributors | Director/Board Member Corporate Officer/Principal Director/Board Member | |
| Lingnan (University) College, Sun Yat Sen University | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Aoyuan Group (Guangdong) Co., Ltd.
 Aoyuan Group (Guangdong) Co., Ltd. Financial ConglomeratesFinance Aoyuan Group (Guangdong) Co., Ltd. engages in the businesses of real estate development and operation; and capital investment. It also provides property management, corporate image planning, marketing planning, and real estate agency services. The company was founded on February 11, 2015 and is headquartered in Guangzhou, China. | Financial Conglomerates | Director/Board Member Director/Board Member | |
| POLY PROPERTY SERVICES CO., LTD. | Real Estate Development | Corporate Secretary Chief Executive Officer | |
| Wuhan University | College/University | Undergraduate Degree Undergraduate Degree | |
| Xiamen University | College/University | Undergraduate Degree Undergraduate Degree | |
| The Hong Kong University of Science & Technology | College/University | Graduate Degree Doctorate Degree | |
| Renmin University of China | College/University | Doctorate Degree Undergraduate Degree | |
| South China Agricultural University | College/University | Doctorate Degree Comptroller/Controller/Auditor | |
| FUSE GROUP HOLDING INC. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| YATSEN HOLDING LIMITED | Specialty Stores | Chief Executive Officer Founder | |
| BYHEALTH CO., LTD | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
| CHINA AOYUAN GROUP LIMITED | Real Estate Development | Director/Board Member President | |
Shenzhen Kaixian Investment Co., Ltd.
 Shenzhen Kaixian Investment Co., Ltd. Financial ConglomeratesFinance Part of China Aoyuan Group Ltd., Shenzhen Kaixian Investment Co., Ltd. is a company that provides investment services. The company is based in Shenzhen, China. The Chinese company was founded in 2021. The CEO is Yi Tan. | Financial Conglomerates | Chief Executive Officer Director/Board Member | |
| YINSHENG DIGIFAVOR COMPANY LIMITED | Regional Banks | Chief Operating Officer Chief Tech/Sci/R&D Officer | |
Guangdong Aoyuan Commercial Real Estate Group Co., Ltd.
 Guangdong Aoyuan Commercial Real Estate Group Co., Ltd. Real Estate DevelopmentFinance Guangdong Aoyuan Commercial Property Group Ltd. engages in the development and management of real estate properties. Its business activities include real estate advisory, valuation and capital investment services. The company was founded on February 4, 2015 and is headquartered in Guangzhou, China. | Real Estate Development | Director/Board Member Director/Board Member | |
| Jinan University | College/University | Corporate Officer/Principal Masters Business Admin | |
| Guangdong University of Foreign Studies | College/University | Undergraduate Degree Corporate Officer/Principal | |
| GUANGZHOU AUTOMOBILE GROUP CO., LTD. | Motor Vehicles | Director/Board Member Director of Finance/CFO | |
Foshan Water & Environmental Protection Co., Ltd.
 Foshan Water & Environmental Protection Co., Ltd. Water UtilitiesUtilities Foshan Water & Environmental Protection Co., Ltd. is an investment holding company. The company is engaged in providing integrated water environment protection services in Foshan and Guangdong. It operates through the following segments: Running Water Supply, Wastewater & Sludge Treatment and Engineering & Construction. The Running Water Supply segment provides running water supply services. It constructs and operates running water supply projects and provides O&M services to running water supply facilities. The Wastewater and Sludge Treatment segment treats and discharges wastewater and sludge in compliance with applicable national and local standards. The Engineering & Construction segment engineers and constructs municipal water supply and drainage infrastructure, environment protection infrastructure, public roadways and municipal landscaping ancillary facilities. The company was founded on January 1, 1964 and is headquartered in Foshan, China. | Water Utilities | Director/Board Member Corporate Officer/Principal | |
| GUANGZHOU BAIYUN ELECTRIC EQUIPMENT CO., LTD. | Electrical Products | Director/Board Member Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| XINJI SHAXI GROUP CO., LTD | Real Estate Development | Director/Board Member | |
Guangdong Hongtai Technology (Holdings) Co. Ltd.
 Guangdong Hongtai Technology (Holdings) Co. Ltd. Metal FabricationProducer Manufacturing Guangdong Hongtai Technology (Holdings) Co. Ltd. is a Chinese company that manufactures die casting parts for the automobile, escalator, and telecommunications industries. The private company is based in Guangdong, China. | Metal Fabrication | President | |
Foshan Water Group Co. Ltd.
 Foshan Water Group Co. Ltd. Water UtilitiesUtilities Foshan Water Group Co. Ltd. is a large state-owned enterprise group based in Foshan, China. Established in 1964, the Chinese company's main business is water supply, sewage treatment, environmental protection, and municipal engineering construction. The private company also offers services such as municipal sludge treatment and disposal, rural sewage treatment, pipeline network detection and leakage, engineering surveying and mapping, and information technology development. The company places a strong emphasis on corporate culture and party building, with regular training classes for party members. The company has been recognized as a "demonstration enterprise of science and technology reform" by the state-owned enterprise reform leading group. The company has also established an emergency command center, big data center, and dispatch center for environmental protection. | Water Utilities | Corporate Officer/Principal | |
| Zhaoqing Gaoyao Hongyi Information Co. Ltd. | Director/Board Member | ||
Foshan Construction & Development Group Co., Ltd.
 Foshan Construction & Development Group Co., Ltd. Financial ConglomeratesFinance Foshan Construction Development Investment Co., Ltd. provides urban construction services. Its business activities include investment and management of public facilities and property assets, electromyography, engineering project investment consulting, financial consulting, property management services, and engineering design and consulting. The company was founded on February 3, 2012 and is headquartered in Foshan, China. | Financial Conglomerates | Corporate Secretary | |
| Ascentage Pharma Group, Inc. | Director/Board Member | ||
| Shenzhen Development Bank /Foshan Branch/ | Corporate Officer/Principal | ||
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Biotechnology | Chief Executive Officer | |
| Foshan City Tianyu Decoration Engineering Co. Ltd. | Corporate Officer/Principal | ||
Ascentage Pharma Group Corp. Ltd.
 Ascentage Pharma Group Corp. Ltd. Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Ascentage Pharma Group Corp. Ltd. is a Chinese biopharmaceutical company. The company is based in Hong Kong, Hong Kong. The company was founded by Shao Meng Wang. | Pharmaceuticals: Major | Director/Board Member | |
| Ascentage International Ltd. | Director/Board Member | ||
| Shanghai Yasheng Pharmaceutical Technology Co., Ltd. | Director/Board Member | ||
Guangdong Foshan Yunfu Industrial Park Investment Development
 Guangdong Foshan Yunfu Industrial Park Investment Development Financial ConglomeratesFinance Guangdong Foshan Yunfu Industrial Park Investment Development provides investment services. The private company is based in Yunfu, China. | Financial Conglomerates | Director/Board Member | |
| Jiangsu Ascentage Pharma Pty Ltd. | Director/Board Member | ||
China Construction Bank (Foshan Branch)
 China Construction Bank (Foshan Branch) Regional BanksFinance China Construction Bank (Foshan Branch) provides banking services. The private company is based in Foshan, China. | Regional Banks | Corporate Officer/Principal | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree | |
| Jimei University | College/University | Undergraduate Degree | |
S*BIO Pte Ltd.
 S*BIO Pte Ltd. Pharmaceuticals: MajorHealth Technology S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multikinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmaceuticals, Inc. for its development and commercialization. In line with its vision to be a leading fully-integrated oncology-focused biotech company in Asia Pacific, S*BIO has established a state-of-the-art R&D infrastructure, complemented by a strong clinical development team. S*BIO has strong links with a network of medical oncologists in Asia Pacific and its investors include EDB Investments' biomedical sciences subsidiary Bio*One Capital, Aravis Ventures, Novartis Bioventures and other international funds. In 2009, S*BIO received the BioSpectrum Editor's Choice, Emerging BioScience Company of Singapore Award. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of North Carolina at Chapel Hill | College/University | Graduate Degree | |
| Michigan State University | College/University | Doctorate Degree | |
| George Washington University | College/University | Doctorate Degree | |
Moody's Investors Service, Inc.
 Moody's Investors Service, Inc. Insurance Brokers/ServicesFinance Moody's Investors Service, Inc. is a credit rating and investment research firm headquartered in New York City. They are a subsidiary of Moody's Corp. (NYSE: MCO). The firm performs international financial research and analysis on commercial and government entities and provides a variety of analytic tools for assessing credit risk. Their clients include creditors, investment banks and commercial banks. | Insurance Brokers/Services | Analyst-Fixed Income | |
| Fujian Guanhong Industrial Co. Ltd. | Corporate Officer/Principal | ||
| Xiamen Juxin Investment Co. Ltd. | Director of Finance/CFO | ||
| The Chinese Biopharmaceutical Association | President | ||
Ascentage Pharma Suzhou Co Ltd
 Ascentage Pharma Suzhou Co Ltd Pharmaceuticals: MajorHealth Technology Part of Ascentage Pharma Group International Co., Ltd., Suzhou Ascentage Pharma Co., Ltd. is a pharmaceutical company. Suzhou Ascentage Pharma Co., Ltd. is based in Suzhou, China. The Chinese company was founded in 2016 by Guang Feng Wang. The CEO is Da Jan Yang. | Pharmaceuticals: Major | Chief Executive Officer |
Statistics
International
| China | 35 |
| United States | 10 |
| Hong Kong | 4 |
| Cayman Islands | 2 |
| Australia | 2 |
Sectoral
| Consumer Services | 15 |
| Finance | 12 |
| Health Technology | 6 |
| Utilities | 3 |
| Producer Manufacturing | 3 |
Operational
| Director/Board Member | 180 |
| Independent Dir/Board Member | 80 |
| Corporate Officer/Principal | 78 |
| Undergraduate Degree | 73 |
| Graduate Degree | 37 |
Most connected contacts
| Insiders | |
|---|---|
| Chu Yuan Li | 17 |
| Rui Lu | 16 |
| Xi Wang | 13 |
| Da Jan Yang | 12 |
| Zhi Bin Chen | 11 |
| Biao Yang | 10 |
| Jian Hua Liu | 10 |
| Xiao Yao Xie | 10 |
| Sheng Lan Li | 8 |
| Yuejun Li | 8 |
| Xingshi Chen | 8 |
| Dan Wang | 8 |
| Yi Tan | 8 |
| Wen Cheng | 8 |
| Wei Bing Han | 8 |
- Stock Market
- Insiders
- Song Chungen
- Company connections